The collaboration is designed to bring metabolic health insights into people's daily routines th

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Goog

Abbott's Medical Devices growth, EPD momentum and improving Nutrition support its outlook, but China

AbbVie relies on a high-margin biopharmaceutical portfolio and significant free cash flow to drive s

Investors interested in stocks from the Medical - Products sector have probably already heard of Env

Abbott broadens Diagnostics growth with Exact Sciences, as Cancer Diagnostics gains and resilient ro

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) currently trades at $105.70, while the Street'

Chelsea Counsel Co. decreased its holdings in shares of Abbott Laboratories (NYSE: ABT) by 23.5% in

Abbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, an

Abbott Laboratories leverages a diversified portfolio across medical devices and diagnostics, bolste

Bank of America Corp DE cut its position in Abbott Laboratories (NYSE: ABT) by 2.8% in the undefined

These companies' recent headwinds shouldn't lead to decreased payouts.

Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings

UBS analyst Patrick Wood maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price

ABT is expanding across diabetes care, oncology diagnostics and heart devices, with new launches and

Abbott Laboratories  ABT has a stronger earnings setup after a second-quarter beat and a higher prof

Screening is for colorectal cancer (CRC) in adults 45 and older who are at average risk for the dise

– Approval expands colorectal cancer screening options for the up to 60 million Americans who are ov

Bank of Nova Scotia lessened its holdings in shares of Abbott Laboratories (NYSE: ABT) by 16.8% in t

Companies raising guidance, particularly on the earnings front, always deserve some level of attenti

ISRG's expanding robotic surgery ecosystem and innovation pipeline give it an edge over Abbott for i

B&D White Capital Company LLC bought a new stake in shares of Abbott Laboratories (NYSE: ABT) during

ABN Amro Investment Solutions increased its stake in Abbott Laboratories (NYSE: ABT) by 10.9% in the

It looks like a great buy-and-hold option.

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises t

Piper Sandler analyst Adam Maeder reiterates Abbott Laboratories (NYSE:ABT) with a Overweight and

JP Morgan analyst Robbie Marcus maintains Abbott Laboratories (NYSE:ABT) with a Overweight and ra

Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight an

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintai

Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. A

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform

RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and

Recent analyst rating changes, top names such as PPG, SAH, ISRG, MMM, OKE, GLDG, ABT, NFLX, TSCO, an

ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow

BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the pr

Market sentiment declined as stocks fell, with tech stocks leading the way. UnitedHealth Group and A

Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its fu

A semiconductor selloff sank the Nasdaq 100 more than 1% while UnitedHealth's blowout quarter li

Abbott Laboratories stock surged over 13% Thursday after second-quarter earnings topped estimates an

Abbott Laboratories (NYSE:ABT) released second-quarter financial results and hosted an earnings call

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto

Abbott Laboratories (NYSE:ABT) raises FY2026 Adj EPS guidance from $5.38-$5.58 to $5.45-$5.60 vs $5.

Companies Reporting Before The Bell • U.S. Bancorp (NYSE:USB) is likely to report quarterly earnings

US stock futures mixed, investors to focus on UnitedHealth, J B Hunt, Abbott, TSMC and GE Aerospace

U.S. stocks gain, led by Amazon and Alphabet. Apple hits record high. Aehr Test Systems and Morgan S

Earnings focus on Thurs, Benzinga-selected slate: industrial engines, logistics real estate, streami

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform

Top Wall Street analysts changed their outlook on top names. See the latest analyst ratings and cove

Baird analyst David Rescott initiates coverage on Abbott Laboratories (NYSE:ABT) with a Outperfor

https://www.wsj.com/us-news/law/the-baby-formula-probe-produced-a-pile-of-evidence-then-the-doj-drop